Neuroone Medical Technologies is trading 7.55% lower at $0.98 in pre-market, with no confirmed company-specific explanation.
- The price compares with the October 14 close of $1.06; no new company-specific announcement explaining the October 15 pre-market move surfaced in the search.
- The latest company news found was October 5 preliminary revenue growth and a record purchase order, which does not clearly explain the decline.
- Hotter-than-expected U.S. inflation raised rate concerns and weighed on equities, particularly technology shares. Healthcareβs pre-market strength does not appear to explain the decline; the macro backdrop is plausible context, not a confirmed direct cause.